The Global Breast Cancer Disparity Strategies for Bridging the Gap

被引：3

作者：

de Souza, Jonas A. ^{[2
,3
]}

Bines, Jose ^{[1
]}

机构：

[1] INCA, Inst Nacl Canc, BR-20560200 Rio De Janeiro, Brazil

[2] Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

[3] Univ Chicago, Global Hlth Initiat, Chicago, IL 60637 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 23期

关键词：

ENDOCRINE THERAPY; LAPATINIB;

D O I：

10.1001/jama.2009.1857

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：2589 / 2590

页数：2

共 10 条

[1]

Effective but Cost-Prohibitive Drugs in Breast Cancer Treatment [J].

Bines, Jose ;

Eniu, Alexandru .

CANCER, 2008, 113 (08) :2353-2358

[2]

Cohen EE, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.12.0758

[3]

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics [J].

Ellis, Matthew J. ;

Tao, Yu ;

Luo, Jingqin ;

A'Hern, Roger ;

Evans, Dean B. ;

Bhatnagar, Ajay S. ;

Ross, Hilary A. Chaudri ;

von Kameke, Alexander ;

Miller, William R. ;

Smith, Ian ;

Eiermann, Wolfgang ;

Dowsett, Mitch .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) :1380-1388

[4]

Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study [J].

Ellis, Matthew J. ;

Gao, Feng ;

Dehdashti, Farrokh ;

Jeffe, Donna B. ;

Marcom, P. Kelly ;

Carey, Lisa A. ;

Dickler, Maura N. ;

Silverman, Paula ;

Fleming, Gini F. ;

Kommareddy, Aruna ;

Jamalabadi-Majidi, S. ;

Crowder, Robert ;

Siegel, Barry A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (07) :774-780

[5]

Guideline Implementation for Breast Healthcare in Low- and Middle-income Countries: Treatment Resource Allocation [J].

Eniu, Alexandru ;

Carlson, Robert W. ;

El Saghir, Nagi S. ;

Bines, Jose ;

Bese, Nuran Senel ;

Vorobiof, Daniel ;

Masetti, Riccardo ;

Anderson, Benjamin O. .

CANCER, 2008, 113 (08) :2269-2281

[6]

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer [J].

Gomez, Henry L. ;

Doval, Dinesh C. ;

Chavez, Miguel A. ;

Ang, Peter C. -S. ;

Aziz, Zeba ;

Nag, Shona ;

Ng, Christina ;

Franco, Sandra X. ;

Chow, Louis W. C. ;

Arbushites, Michael C. ;

Casey, Michelle A. ;

Berger, Mark S. ;

Stein, Steven H. ;

Sledge, George W. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :2999-3005

[7]

Gronwald J, 2009, J CLIN ONCOL, V27

[8]

OLOPADE OL, 2009, ASCO ED BOOK, P681

[9]

Clinical Practice Patterns and Cost Effectiveness of Human Epidermal Growth Receptor 2 Testing Strategies in Breast Cancer Patients [J].

Phillips, Kathryn A. ;

Marshall, Deborah A. ;

Haas, Jennifer S. ;

Elkin, Elena B. ;

Liang, Su-Ying ;

Hassett, MichaelJ. ;

Ferrusi, Ilia ;

Brock, Jane E. ;

Van Bebber, Stephanie L. .

CANCER, 2009, 115 (22) :5166-5174

[10]

Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer:: A modeling analysis [J].

Punglia, Rinaa S. ;

Burstein, Harold J. ;

Winer, Eric P. ;

Weeks, Jane C. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :642-648

← 1 →